Isbn: 9798242195561 - biolionaire scientist—volume 4: cellular empire: where cell therapy becomes an industry (8 resultados)

Condición: New.

Condición: As New. Unread book in perfect condition.

PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. Print on Demand.

Paperback. Condición: new. Paperback. Cellular Empire explores the rise of living drugs - from early T-cell biology to engineered cellular therapies that are redefining oncology and regenerative medicine.This volume examines how cell therapy evolved from experimental immunology into a manufacturing-driven, venture-backed industry. It connects the biological foundations of T cells and stem cells with the engineering logic behind chimeric antigen receptor (CAR) platforms, induced pluripotent stem cell (iPSC) technologies, and next-generation delivery systems.Rather than treating cell therapy as a scientific novelty, this book analyzes the full architecture of platform development: biological mechanism, genetic engineering, manufacturing scalability, regulatory realities, solid tumor challenges, and commercialization pathways. It also addresses what it means to become a builder in this field - moving from bench scientist to founder.Designed for clinician-scientists, graduate researchers, translational innovators, and biotech entrepreneurs, Cellular Empire bridges immunology, bioengineering, and capital formation to show how living drugs become global therapeutic platforms.Who This Book Is ForThis volume is written for graduate students, postdoctoral fellows, clinician-scientists, translational research teams, cell therapy engineers, and biotechnology founders seeking a rigorous understanding of engineered cell platforms. It is also appropriate for institutional libraries, cancer centers, and biotech incubators training future innovators.Table of ContentsPart I - The Science of Living DrugsChapter 1 - The Birth of Living DrugsChapter 2 - T Cells: Nature's Programmable SoldiersChapter 3 - Engineering CAR T CellsChapter 4 - Manufacturing a Cell TherapyPart II - Next-Gen TherapyChapter 5 - CAR NK and the Rise of Cell TherapiesChapter 6 - iPSCs and Stem Cell EngineeringChapter 7 - Delivery Platforms for Living DrugsChapter 8 - Cell Therapy in Solid TumorsPart III - The Business & The BuilderChapter 9 - The Business of Cell TherapyChapter 10 - Becoming a Cell Therapy FounderAppendicesAppendix A - Example SBIR Phase I Grant ProposalAppendix B - Example SBIR Phase II Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Paperback. Condición: new. Paperback. Cellular Empire explores the rise of living drugs - from early T-cell biology to engineered cellular therapies that are redefining oncology and regenerative medicine.This volume examines how cell therapy evolved from experimental immunology into a manufacturing-driven, venture-backed industry. It connects the biological foundations of T cells and stem cells with the engineering logic behind chimeric antigen receptor (CAR) platforms, induced pluripotent stem cell (iPSC) technologies, and next-generation delivery systems.Rather than treating cell therapy as a scientific novelty, this book analyzes the full architecture of platform development: biological mechanism, genetic engineering, manufacturing scalability, regulatory realities, solid tumor challenges, and commercialization pathways. It also addresses what it means to become a builder in this field - moving from bench scientist to founder.Designed for clinician-scientists, graduate researchers, translational innovators, and biotech entrepreneurs, Cellular Empire bridges immunology, bioengineering, and capital formation to show how living drugs become global therapeutic platforms.Who This Book Is ForThis volume is written for graduate students, postdoctoral fellows, clinician-scientists, translational research teams, cell therapy engineers, and biotechnology founders seeking a rigorous understanding of engineered cell platforms. It is also appropriate for institutional libraries, cancer centers, and biotech incubators training future innovators.Table of ContentsPart I - The Science of Living DrugsChapter 1 - The Birth of Living DrugsChapter 2 - T Cells: Nature's Programmable SoldiersChapter 3 - Engineering CAR T CellsChapter 4 - Manufacturing a Cell TherapyPart II - Next-Gen TherapyChapter 5 - CAR NK and the Rise of Cell TherapiesChapter 6 - iPSCs and Stem Cell EngineeringChapter 7 - Delivery Platforms for Living DrugsChapter 8 - Cell Therapy in Solid TumorsPart III - The Business & The BuilderChapter 9 - The Business of Cell TherapyChapter 10 - Becoming a Cell Therapy FounderAppendicesAppendix A - Example SBIR Phase I Grant ProposalAppendix B - Example SBIR Phase II Grant ProposalGlossaryIndexCompanies Discussed in this VolumeEssential Reading This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…